YHB Investment Advisors Inc. Buys 6,776 Shares of Danaher Co. (DHR)

YHB Investment Advisors Inc. lifted its stake in shares of Danaher Co. (NYSE:DHR) by 6.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 106,825 shares of the conglomerate’s stock after purchasing an additional 6,776 shares during the quarter. Danaher comprises 2.0% of YHB Investment Advisors Inc.’s portfolio, making the stock its 10th largest position. YHB Investment Advisors Inc.’s holdings in Danaher were worth $11,016,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Belpointe Asset Management LLC acquired a new stake in Danaher in the 3rd quarter valued at approximately $121,000. Reilly Financial Advisors LLC increased its position in Danaher by 62.6% in the 3rd quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after acquiring an additional 501 shares during the period. NEXT Financial Group Inc acquired a new stake in Danaher in the 3rd quarter valued at approximately $166,000. Bartlett & Co. LLC increased its position in Danaher by 187.2% in the 3rd quarter. Bartlett & Co. LLC now owns 1,611 shares of the conglomerate’s stock valued at $175,000 after acquiring an additional 1,050 shares during the period. Finally, Rehmann Capital Advisory Group increased its position in Danaher by 11.2% in the 3rd quarter. Rehmann Capital Advisory Group now owns 1,790 shares of the conglomerate’s stock valued at $195,000 after acquiring an additional 181 shares during the period. Institutional investors and hedge funds own 77.03% of the company’s stock.

DHR has been the topic of several research analyst reports. Cowen reiterated a “buy” rating and set a $110.00 price target on shares of Danaher in a research report on Monday. Needham & Company LLC initiated coverage on Danaher in a research report on Wednesday, January 2nd. They set a “buy” rating and a $114.00 price target on the stock. Robert W. Baird lowered their price target on Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday, October 19th. Morgan Stanley lifted their price target on Danaher from $122.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, October 10th. Finally, Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research report on Wednesday, September 19th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Danaher presently has a consensus rating of “Buy” and a consensus price target of $112.28.

In related news, CFO Daniel L. Comas sold 36,000 shares of Danaher stock in a transaction on Thursday, November 8th. The stock was sold at an average price of $103.88, for a total transaction of $3,739,680.00. Following the completion of the sale, the chief financial officer now owns 124,218 shares of the company’s stock, valued at $12,903,765.84. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider William King sold 53,433 shares of Danaher stock in a transaction on Monday, November 5th. The shares were sold at an average price of $101.64, for a total value of $5,430,930.12. Following the sale, the insider now directly owns 36,425 shares of the company’s stock, valued at approximately $3,702,237. The disclosure for this sale can be found here. In the last three months, insiders have sold 150,007 shares of company stock valued at $15,202,163. Insiders own 11.90% of the company’s stock.

Shares of Danaher stock traded down $0.10 during midday trading on Friday, hitting $105.26. The company’s stock had a trading volume of 110,803 shares, compared to its average volume of 2,952,726. The stock has a market cap of $73.15 billion, a PE ratio of 26.12, a price-to-earnings-growth ratio of 1.91 and a beta of 1.00. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.38. Danaher Co. has a 1-year low of $91.84 and a 1-year high of $110.86.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.03. The business had revenue of $4.85 billion during the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a return on equity of 11.59% and a net margin of 14.07%. Danaher’s revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 earnings per share. Analysts expect that Danaher Co. will post 4.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 25th. Investors of record on Friday, December 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.61%. Danaher’s payout ratio is 15.88%.

ILLEGAL ACTIVITY NOTICE: “YHB Investment Advisors Inc. Buys 6,776 Shares of Danaher Co. (DHR)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://sportsperspectives.com/2019/01/11/yhb-investment-advisors-inc-buys-6776-shares-of-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Read More: Bollinger Bands

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply